- Previous Close
0.0575 - Open
0.0575 - Bid 0.0540 x 5270000
- Ask 0.0655 x 5270000
- Day's Range
0.0575 - 0.0575 - 52 Week Range
0.0315 - 0.0645 - Volume
0 - Avg. Volume
0 - Market Cap (intraday)
606.096M - Beta (5Y Monthly) 0.24
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0000 - Earnings Date Mar 18, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date May 23, 2023
- 1y Target Est
--
CK Life Sciences Int'l., (Holdings) Inc., an investment holding company, researches, develops, manufactures, commercializes, markets, and sells health and agriculture-related products in the Asia Pacific and North America. It manufactures and markets plant protection products and soluble fertilizers; manufactures, blends, distributes, and sells fertilizers, pesticides, and related agricultural products; manufactures and distributes horticultural products for the home gardening market; and produces non-sterile prescription and over-the-counter medicines. The company is also involved in the contract manufacturing of complementary healthcare medicines, pharmaceutical products, and cosmetics; licensing of registration activities and the importation of finished agricultural goods; holding of land and buildings; financing activities; investment in financial instruments and vineyards; trading of biotechnology products and nutritional supplements; and manufacturing, wholesaling, retailing, and distribution of nutraceutical products. In addition, it distributes turf management machinery, hardware, equipment, and accessories, as well as turf fertilizers, chemicals, and professional pest products; produces, refines, and distributes salt products; and provides research and development services for biotechnology and life sciences technology products. Further, it researches, develops, manufactures, and commercializes drug products to treat pain and melanoma; supplies raw materials for nutritional health, pharmaceutical, cosmetics, personal care, and food segments; and offers packing and asset management services. The company was founded in 1999 and is headquartered in Tai Po, Hong Kong.
www.ck-lifesciences.comRecent News: LSI.F
View MorePerformance Overview: LSI.F
Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: LSI.F
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: LSI.F
View MoreValuation Measures
Market Cap
616.63M
Enterprise Value
1.27B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.86
Price/Book (mrq)
1.35
Enterprise Value/Revenue
1.94
Enterprise Value/EBITDA
31.77
Financial Highlights
Profitability and Income Statement
Profit Margin
-2.29%
Return on Assets (ttm)
0.44%
Return on Equity (ttm)
-3.29%
Revenue (ttm)
5.52B
Net Income Avi to Common (ttm)
-126.55M
Diluted EPS (ttm)
-0.0000
Balance Sheet and Cash Flow
Total Cash (mrq)
571.21M
Total Debt/Equity (mrq)
173.70%
Levered Free Cash Flow (ttm)
--